• Skip to primary navigation
  • Skip to main content
  • Skip to footer
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

Hide Search
Shopping Cart
Show SearchSearch
866.626.6847
  • About
    • Our Work
    • Our Team
    • Our Partners
  • Exposures
    • Pregnancy and Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
    • LactRx App
  • Studies
    • Ongoing Studies
    • What’s Involved?
    • Join Now
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Meetings
    • FAQs
    • OTIS Membership
  • Media
    • Media Requests
    • Press Releases
    • eNews Sign Up
  • In Your Area
  • OTIS
    • About OTIS
    • OTIS Membership
    • Annual Meeting
    • Member Log-In
    • Donate
  • Contact
  • Show SearchSearch

Thalidomide

May 1, 2021

Selected References

  • Brooks C, et al. 1977. Linear growth of children with limb deformities following exposure to thalidomide in utero. Acta Paediatr Scan 66:673-675.
  • Castilla E, et al. 1996. Thalidomide, a current teratogen in South America. Teratology 54:273-277.
  • Gao S, et al. 2020. Recent advances in the molecular mechanism of thalidomide teratogenicity. Biomed Pharmacother. ;127:110114. doi: 10.1016/j.biopha.2020.110114. Epub 2020 Apr 15.
  • Gollop T, et al. 1987. Prenatal diagnosis of thalidomide syndrome. Prenat Diagn 7:295-298.
  • Ito T, et al. 2020. Molecular mechanisms of thalidomide and its derivatives. Proc Jpn Acad Ser B Phys Biol Sci.;96(6):189-203.
  • Miller MT, et al. 2009. Thalidomide and misoprostol: Opthalmologic manifestations and associations both expected and unexpected. Birth Defects Res A Clin Mol Teratol. 85(8):667-676.
  • Peng X, et al. 2017. Thalidomide results in diminished ovarian reserve in reproductive age female IBD patients. Medicine (Baltimore) 96(21):e6540.
  • Prescriber Guide to (THALOMID REMS™ ) Risk Evaluation and Mitigation Strategy (REMS)™ Program . (2014). Retrieved from https://www.fda.gov/media/79047/download
  • Rodier PM, 2000. The Early Origins of Autism, Scientific American 282:56-63.
  • Rodier PM. 2002. Converging evidence for brain stem injury in autism. Dev Psychopathol. ;14(3):537-57.
  • Smithells R. 1992. Recognition of thalidomide defects. J Med Genet 29:716-723.
  • Sterling D, et al. 1997. Thalidomide: a surprising recovery. J Am Pharm Assn 3:306-313.
  • Stromland K, et al. 1993. Thalidomide embryopathy: revisited 27 years later. Acta Ophthalmol (Copen) 71:238-245.

Footer

           

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Asthma
  • Coronavirus (COVID-19)
  • Crohn’s Disease
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Juvenile Idiopathic Arthritis
  • Multiple Sclerosis
  • Pertussis/Tdap vaccine (“Whooping Cough” vaccine)
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Ulcerative Colitis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists
OTIS Logo

Copyright © 2023 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^